Paxlovid for Treatment of Long Covid

NCT05576662 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Post-acute Sequelae of SARS-CoV-2 Infection
Long COVID

Interventions

DRUG: Nirmatrelvir
DRUG: Placebo
DRUG: Ritonavir

Sponsor

Stanford University

Collaborators

[object Object]